Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) Fails to deliver data
Key failure to deliver metrics for Bellerophon Therapeutics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0 M
- Last year FTD volume: $6.11 M
Failures to deliver for Bellerophon Therapeutics (BLPH) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Bellerophon Therapeutics (BLPH) - since 2020
Volume in USD (price x number of shares), data since 2020Bellerophon Therapeutics (BLPH) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0 M | -99.93% |
| 2023 | $11.94 M | 1116.91% |
| 2022 | $0.98 M | -89.54% |
| 2021 | $9.37 M | -14.98% |
| 2020 | $11.03 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $62.38 M | $0.13 B | 🇺🇸 USA |
 Baxter BAX | $9.57 M | $54.33 M | 🇺🇸 USA |
 Lantheus Holdings LNTH | $2.07 M | $9.96 M | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $0.37 M | $1.02 M | 🇺🇸 USA |